Key Points
- Director Keith Rosenbloom sold 556,580 American Vanguard shares at an average price of $2.20, generating $1.22 million and reducing his direct ownership by 97.34% to 15,201 shares.
- American Vanguard reported weak quarterly results, posting a $0.34 loss per share versus a $0.09 consensus profit estimate and revenue of $116.75 million, below the $135 million expectation.
- The stock opened at $2.23 and has a market capitalization of $65.78 million; analysts currently assign it an average “Sell” rating, while institutional investors own 79% of the shares.
American Vanguard Corporation (NYSE:AVD - Get Free Report) Director Keith Rosenbloom sold 556,580 shares of the firm's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $2.20, for a total transaction of $1,224,476.00. Following the transaction, the director directly owned 15,201 shares in the company, valued at approximately $33,442.20. The trade was a 97.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
American Vanguard Price Performance
Shares of American Vanguard stock opened at $2.23 on Friday. The company has a current ratio of 2.47, a quick ratio of 1.40 and a debt-to-equity ratio of 1.46. The stock has a market cap of $65.78 million, a PE ratio of -1.17 and a beta of 1.43. American Vanguard Corporation has a 52 week low of $2.03 and a 52 week high of $5.92. The company's 50-day moving average price is $2.58 and its two-hundred day moving average price is $3.12.
American Vanguard (NYSE:AVD - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The basic materials company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.43). The company had revenue of $116.75 million during the quarter, compared to the consensus estimate of $135.00 million. American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%.
Institutional Investors Weigh In On American Vanguard
Hedge funds and other institutional investors have recently modified their holdings of the stock. Potomac Capital Management Inc. acquired a new position in American Vanguard during the 4th quarter valued at $1,751,000. EVR Research LP boosted its holdings in American Vanguard by 82.0% in the 4th quarter. EVR Research LP now owns 618,657 shares of the basic materials company's stock valued at $2,363,000 after purchasing an additional 278,657 shares during the period. Gamco Investors INC. ET AL acquired a new stake in American Vanguard in the 4th quarter worth $229,000. Williams & Novak LLC grew its position in American Vanguard by 97.1% in the 4th quarter. Williams & Novak LLC now owns 30,230 shares of the basic materials company's stock worth $115,000 after purchasing an additional 14,895 shares during the last quarter. Finally, Empowered Funds LLC increased its holdings in shares of American Vanguard by 97.0% during the 1st quarter. Empowered Funds LLC now owns 84,078 shares of the basic materials company's stock worth $209,000 after purchasing an additional 41,388 shares during the period. Institutional investors and hedge funds own 79.00% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the stock. Wall Street Zen downgraded shares of American Vanguard from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. Weiss Ratings reissued a "sell (e+)" rating on shares of American Vanguard in a report on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Sell".
View Our Latest Research Report on AVD
About American Vanguard
(
Get Free Report)
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company's product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
